Craig Lee

Craig Lee is a John A. and Deborah S. McNeill, Jr. Distinguished Professor and Chair of the Division of Pharmacotherapy and Experimental Therapeutics at the UNC Eshelman School of Pharmacy. He holds adjunct appointments in the UNC School of Medicine’s Division of Cardiology and is a member of the McAllister Heart Institute and Program for Precision Medicine in Healthcare.

• Education: Pharm.D. (UNC-Chapel Hill, 2000), Ph.D. in Pharmaceutical Sciences (UNC-Chapel Hill, 2006), and a Fellowship in Clinical Research/Drug Development (UNC/ GlaxoSmithKline).

His research focuses on precision medicine, cytochrome P450 metabolism, and cardiovascular therapeutics. Key areas include genotype-guided antiplatelet therapy, pregnancy drug metabolism, and CYP-derived eicosanoids in cardiometabolic disease. Over 100 manuscripts and abstracts highlight his translational work integrating preclinical and clinical models.

Recent studies emphasize optimizing drug selection/dosing via pharmacogenomics, particularly in high-risk PCI patients and pregnant populations. Collaborations with NIH-funded projects and multi-institutional registries drive his work.

• Grants: NIH/NHLBI Precision PCI Registry, NIH/NICHD pregnancy metabolism studies.
• Awards: Over 40 students advised (PhD, postdocs, PharmD).
• Labs: Craig Lee Lab focuses on precision medicine, pregnancy pharmacology, and eicosanoid pathways.